Chronic Inflammatory Demyelinating PolyneuropathySymptoms, Doctors, Treatments, Advances & More
Chronic Inflammatory Demyelinating Polyneuropathy Overview
Learn About Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a disorder that involves nerve swelling and irritation (inflammation) that leads to a loss of strength or sensation.
Chronic inflammatory demyelinating polyradiculoneuropathy; Polyneuropathy - chronic inflammatory; CIDP; Chronic inflammatory polyneuropathy; Guillain-Barré - CIDP
CIDP is one cause of damage to nerves outside the brain or spinal cord (peripheral neuropathy). Polyneuropathy means several nerves are involved. CIDP often affects both sides of the body.
CIDP is caused by an abnormal immune response. CIDP occurs when the immune system attacks the myelin cover of the nerves. For this reason, CIDP is thought to be an autoimmune disease.
Health care providers also consider CIDP as the chronic form of Guillain-Barré syndrome.
The specific triggers of CIDP vary. In many cases, the cause cannot be identified.
CIDP may cause similar problems as neuropathy occurring in other conditions, such as:
- Chronic hepatitis
- Diabetes
- HIV/AIDS
- Immune system disorders due to cancer
- Inflammatory bowel disease
- Systemic lupus erythematosus
- Cancer of the lymph system
- Overactive thyroid
Symptoms include any of the following:
- Problems walking due to weakness or lack of feeling in the feet
- Trouble using the arms and hands or legs and feet due to weakness
- Sensation changes, such as numbness or decreased sensation, pain, burning, tingling, or other abnormal sensations (usually affects the feet first, then the arms and hands)
Other symptoms that can occur with CIDP include:
- Abnormal or uncoordinated movement
- Problems breathing
- Fatigue
- Hoarseness, changing voice or slurred speech
The goal of treatment is to reverse the attack on the nerves. In some cases, nerves can heal and their function can be restored. In other cases, nerves are badly damaged and cannot heal, so treatment is aimed at preventing the disease from getting worse.
Which treatment is given depends on how severe the symptoms are, among other things. The most aggressive treatment is only given if you have difficulty walking, breathing, or if symptoms don't allow you to care for yourself or work.
Treatments may include:
- Corticosteroids to help reduce inflammation and relieve symptoms
- Other medicines that suppress the immune system (for some severe cases)
- Plasmapheresis or plasma exchange to remove antibodies from the blood
- Intravenous immune globulin (IVIg), which involves injecting antibodies into the bloodstream to reduce the effect of the antibodies that are causing the problem
- Efgartigimod, a biological agent that reduces inflammation that damages nerves
VCU Health - Ambulatory Care Center
Kelly Gwathmey is a Neurologist practicing medicine in Richmond, Virginia. Dr. Gwathmey is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Gastrostomy, and Tissue Biopsy. Dr. Gwathmey is currently accepting new patients.
M Health Fairview EMG Clinic Minneapolis
Jeffrey Allen is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Minneapolis, Minnesota. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Polyradiculoneuritis, Multifocal Motor Neuropathy, and Guillain-Barre Syndrome. Dr. Allen is board certified in Neurology: American Board Of Psychiatry And Neurology, 2008 and Neuromuscular Medicine: American Board Of Psychiatry And Neurology, 2011. Dr. Allen is currently accepting new patients.
Vickie & Jack Farber Institute For Neuroscience - Honickman Center
Marinos Dalakas is a Neurologist and a Neuromusculoskeletal Medicine provider practicing medicine in Philadelphia, Pennsylvania. Dr. Dalakas is rated as an Elite provider by MediFind in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Hereditary Hyperekplexia, Chronic Polyradiculoneuritis, and Laminectomy. Dr. Dalakas is board certified in Neurology.
The outcome varies. The disorder may continue long term, or you may have repeated episodes of symptoms. Complete recovery is possible, but permanent loss of nerve function is not uncommon.
Complications of CIDP include:
- Pain
- Permanent decrease or loss of sensation in areas of the body
- Permanent weakness or paralysis in areas of the body
- Repeated or unnoticed injury to an area of the body
- Side effects of medicines used to treat the disorder
Contact your provider if you have a loss of movement or sensation in any area of the body, especially if your symptoms get worse.
Summary: The purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).
Summary: The main purpose of this study is to demonstrate the efficacy and safety of empasiprubart in adults with CIDP. The study consists of a part A where participants will either receive empasiprubart or placebo for 24 weeks (6 months). Following part A, participants will enter part B in which all participants will receive empasiprubart for 96 weeks (24 months). More information can be found here: https...
Published Date: May 04, 2026
Published By: Joseph V. Campellone, MD, Professor of Neurology, Cooper-Inspira Neuroscience, Cooper Medical School of Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Barnes M, Craig A, Hearn SL. Peripheral nerve disorders. In: Cifu DX, Bowles AO, Eapen BC, et al, eds. Braddom's Physical Medicine and Rehabilitation. 7th ed. Philadelphia, PA: Elsevier; 2026:chap 42.
Katirji B. Disorders of peripheral nerves. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 106.
National Institute of Neurological Disorders and Stroke website. Peripheral neuropathy. www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy. Updated March 13, 2026. Accessed June 3, 2026.
Smith AG, Shy ME. Peripheral neuropathies. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 388.

